1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Corbacho-Loarte MD, Crespillo-Andújar C, Chamorro-Tojeiro S, Norman F, Pérez-Molina JA, Martín O, Rubio JM, Gullón-Peña B, López-Vélez R, Monge-Maillo B.

    Screening of imported malaria infection in asymptomatic migrants from Sub-Saharan Africa: A retrospective analysis of a 2010-2019 cohort

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 49: 102411-102411. Nº de citas: 3

    [doi:10.1016/j.tmaid.2022.102411]

  • Busca C, Arias P, Sánchez-Conde M, Rico M, Montejano R, Martín-Carbonero L, Valencia E, Moreno V, Bernardino JI, Olveira A, Abadía M, González-García J, Montes ML.

    Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD.

    FRONTIERS IN PHARMACOLOGY . 13: 905126-905126.

    [doi:10.3389/fphar.2022.905126]

  • Perez Stachowski J, Rial Crestelo D, Moreno Zamora A, Cabello N, Ryan P, Espinosa Aguilera N, Bisbal O, Vivancos Gallego MJ, Nuñez MJ, Troya J, Dominguez M, Sierra JO.

    Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study.

    Journal Of Clinical Medicine . 11(17): .

    [doi:10.3390/jcm11174994]

  • Hernández-Sampelayo T, Gómez-Pavón J, González Del Castillo J, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, García-Lledó A, Calvo Rey P, Bouza E.

    COVID in Pediatric Age: an opinion paper.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(4): 333-343. Nº de citas: 1

    [doi:10.37201/req/012.2022]

  • Vizcarra P, Rosillo M, del Rey JM, Moreno A, Vivancos MJ, Casado JL.

    Unravelling hip-spine bone mineral density discordance in people living with HIV.

    JOURNAL OF BONE AND MINERAL METABOLISM . 40(6): 990-997.

    [doi:10.1007/s00774-022-01365-z]

  • Casado JL, Vizcarra P, Haemmerle J, Velasco H, Martín-Hondarza A, Rodríguez-Domínguez MJ, Velasco T, Martín S, Romero-Hernández B, Fernández-Escribano M, Vallejo A.

    Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2.

    Vaccine: X . 11: 100165-100165. Nº de citas: 3

    [doi:10.1016/j.jvacx.2022.100165]

  • Fanciulli C, Berenguer J, Busca C, Vivancos MJ, Téllez MJ, Domínguez L, Domingo P, Navarro J, Santos J, Iribarren JA, Morano L, Artero A, Moreno J, Rivero-Román A, Santos I, Giner L, Armiñanzas C, Montero M, Manzardo C, Cifuentes C, García C, Galindo MJ, Ferrero OL, Sanz J, de la Fuente B, Rodríguez C, Gaspar G, Pérez L, Losa JE, Force L, Veloso S, Martínez-Alfaro E, Jarrín I, De Miguel M, González Garcia J.

    Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019

    HIV MEDICINE . 23(7): 705-716. Nº de citas: 9

    [doi:10.1111/hiv.13229]

  • Parro-Torres C, Hernández-Huerta D, Ochoa-Mangado E, Pérez-Elías MJ, Baca-García E, Madoz-Gúrpide A.

    Antiretroviral treatment adherence and mental disorders: observational case-control study in people living with HIV in Spain

    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV . 34(8): 1-9.

    [doi:10.1080/09540121.2021.1944598]

  • Romero-Hernández B, Martínez-García L, Rodríguez-Dominguez M, Martínez-Sanz J, Vélez-Díaz-Pallarés M, Pérez Mies B, Muriel A, Gea F, Pérez-Elías MJ, Galán JC.

    The Negative Impact of COVID-19 in HCV, HIV, and HPV Surveillance Programs During the Different Pandemic Waves.

    Frontiers in Public Health . 10: 880435-880435. Nº de citas: 1

    [doi:10.3389/fpubh.2022.880435]

  • Sainz T, Casas I, González-Esguevillas M, Escosa-Garcia L, Muñoz-Fernández MÁ, Prieto L, Gosalbes MJ, Jiménez-Hernández N, Ramos JT, Navarro ML, Mellado MJ, Serrano-Villar S, Calvo C.

    Nutritional Supplementation to Increase Influenza Vaccine Response in Children Living With HIV: A Pilot Clinical Trial

    Frontiers in Pediatrics . 10: 919753-919753.

    [doi:10.3389/fped.2022.919753]

  • Mendes FSNS, Perez-Molina JA, Angheben A, Meymandi SK, Sosa-Estani S, Molina I.

    Critical analysis of Chagas disease treatment in different countries.

    MEMORIAS DO INSTITUTO OSWALDO CRUZ . 117: .

    [doi:10.1590/0074-02760210034]

  • Martínez-Sanz J, Calvo MV, Serrano-Villar S, Montes ML, Martín-Mateos R, Burgos-Santamaría D, Díaz-Álvarez J, Talavera-Rodríguez A, Rosas M, Moreno S, Fontecha J, Sánchez-Conde M.

    Effects of HIV Infection in Plasma Free Fatty Acid Profiles among People with Non-Alcoholic Fatty Liver Disease.

    Journal Of Clinical Medicine . 11(13): .

    [doi:10.3390/jcm11133842]

  • Bohbot Y, Habib G, Laroche C, Stöhr E, Chirouze C, Hernandez-Meneses M, Melissopoulou M, Mutlu B, Scheggi V, Branco L, Olmos C, Reyes G, Pazdernik M, Iung B, Sow R, Mirocevic M, Lancellotti P, Tribouilloy C.

    Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry.

    EUROPEAN JOURNAL OF HEART FAILURE . 24(7): 1253-1265.

    [doi:10.1002/ejhf.2525]

  • Martínez-Sanz J, Serrano-Villar S, Muriel A, Fraile LJG, Orviz E, de Cea ÁM, Campins AA, Moreno S.

    Metabolic-related outcomes after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in adults with HIV: a multicenter prospective cohort study.

    CLINICAL INFECTIOUS DISEASES . 76(3): 652-660.

    [doi:10.1093/cid/ciac621]

  • Montejano R, de la Calle-Prieto F, Velasco M, Guijarro C, Queiruga-Parada J, Jiménez-González M, González-Ruano P, Martínez P, Goikoetxea AJ, Ibarrola M, Ciudad M, Gutiérrez Á, Torralba M, Díaz-Brasero A, Ryan P, Marcelo C, Díez C, Ibarra S, Merino E, Estrada V, Marcos J, Novella M, Rivera MA, Ruiz-Muñoz M, de Miguel M, Soler L, Del Álamo M, Moreno S, Carcas AJ, Borobia AM, Arribas JR.

    Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial.

    CLINICAL INFECTIOUS DISEASES . : . Nº de citas: 1

    [doi:10.1093/cid/ciac628]

  • Busca C, Sánchez-Conde M, Rico M, Rosas M, Valencia E, Moreno A, Moreno V, Martín-Carbonero L, Moreno S, Pérez-Valero I, Bernardino JI, Arribas JR, González J, Olveira A, Castillo P, Abadía M, Guerra L, Mendez C, Montes ML.

    Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens.

    Open forum infectious diseases . 9(7): .

    [doi:10.1093/ofid/ofac279]

  • Jiménez D, Martínez-Sanz J, Sainz T, Calvo C, Méndez-Echevarría A, Moreno E, Blázquez-Gamero D, Vizcarra P, Rodríguez M, Jenkins R, Sánchez-Conde M, Ron R, Norman F, Moreno S, Ferrer M, Serrano-Villar S.

    Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2.

    JOURNAL OF INFECTION . 85(1): 86-89.

    [doi:10.1016/j.jinf.2022.04.041]

  • Escudero-Sanchez R, Muriel García A, García Fernández S, Valencia Alijo A, Tasias Pitarch M, Merino De Lucas E, Gutierrez Rojas A, Ramos Martínez A, Salavert Lletí M, Giner L, Ruíz Ruigomez M, García Basas L, Fernández Fradejas J, Olmedo Sampedrio M, Cano Yuste A, Díaz Pollán B, Rodríguez Hernández MJ, Martín Segarra O, Sáez Bejar C, Armiñanzas Castillo C, Gutiérrez B, Rodríguez-Pardo D, De La Torre Cisneros J, López Medrano F, Cobo Reinoso J.

    Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 77(7): 1996-2002. Nº de citas: 4

    [doi:10.1093/jac/dkac106]